Background
In female mammals, reproductive capacity is determined at birth by the non-renewable pool of primordial follicles present, representing the total population of germ cells available for reproductive purposes [
1]. In mice, the primordial germ cells migrate to the genital ridge and divide by mitosis until 13.5 days postcoitum (dpc) [
2]. During these divisions the germ cells are known as oogonia and develop in germ cell cysts due to incomplete cytokinesis following each cell cycle [
3]. Oogonia start to enter meiosis at approximately 13.5 dpc and are then referred to as oocytes [
2]. Oogonia do not appear to enter meiosis synchronously [
2,
4]. However, meiosis proceeds from anterior to posterior suggesting that local factors diffuse from the mesonephros at the anterior side of the ovary to promote meiosis [
5]. Most germ cells have entered meiosis by 15.5 dpc [
2]. After entering meiosis oocytes progress through the initial stages of meiotic prophase I and remain arrested at the diplotene stage until just prior to ovulation. Some oocytes arrive at the diplotene stage by 17.5 dpc but it takes several days until all oocytes are in diplotene [
2]. During the same time period, germ cell cysts break apart and individual oocytes become surrounded by granulosa cells forming primordial follicles [
6]. Some follicles, referred to as the first wave of developing follicles are activated to grow immediately after forming while most follicles are not activated until sexual maturity developing in groups in a cyclical fashion [
7,
8].
Mutations in genes responsible for the initial stages of meiosis in mouse such as disrupted meiotic cDNA 1 (
Dmc1) and meiosis-specific sporulation protein (
Spo11) result in loss of oocytes and an inability to form follicles which ultimately cause sterility [
9,
10]. Meiotic prophase I is marked by the expression of synaptonemal complex proteins (SYCPs) that make up the synaptonemal complex which is required for DNA synapsis and meiotic recombination between homologous chromosomes. In rats, inhibition of SYCP1 accelerated arrival at the diplotene stage along with premature assembly of those oocytes into primordial follicles [
11]. In fetal bovine ovaries, many oocytes do not appear to arrest at diplotene but instead continue on through diakinesis where they are eventually lost by attrition [
12]. A crucial factor for the survival of germ cells may be their ability to be enclosed within follicles [
13]. This evidence reflects the possibility of a link between two events that occur during early mouse oogenesis, arrest at the diplotene stage and primordial follicle formation.
Both estradiol (E
2) and progesterone (P
4) can delay cyst breakdown and primordial follicle formation [
14]. Estrogens have also been shown to affect meiotic progression of oocytes. When pregnant mice were treated with bisphenol A (BPA), a known estrogenic compound, oocytes from female fetuses of exposed mothers had synaptic defects and recombination aberrations [
15]. In adults, those aberrations gave rise to aneuploid eggs and embryos. In cattle, it is thought that primordial follicles cannot be activated until after the oocyte reaches diplotene arrest. In vitro treatment of bovine ovaries with estradiol (E
2) or progesterone (P
4) decreased the number of follicles that were activated and thus, may affect progression to the diplotene stage [
16].
The main objectives of the present study were to determine if diplotene arrest is linked with primordial follicle formation in mice and to elucidate the role of steroid hormone signaling in meiotic progression of murine oocytes. The molecular mechanisms involved in regulating progression through prophase I and in primordial follicle formation in the developing ovary are still poorly understood. Elucidating events during fetal ovarian development will increase our understanding of the factors that control oocyte quality and quantity and thus help in improvement of current infertility treatments.
Methods
Animals
Adult CD1 male and female outbred mice were obtained from Charles River Laboratories (Wilmington, MA, USA) and were maintained in accordance with the policies of Syracuse University’s Institutional Animal Care and Use Committee. Mice were housed and bred at a controlled photoperiod (14 h light, 10 h dark), temperature (21–22 °C), and humidity with food and water available ad libitum. CD1 females were mated with males of the same strain and checked daily for vaginal plugs. Noon on the day of vaginal plug detection was designated as 0.5 dpc. Birth usually occurred at 19.5 dpc and was designated as postnatal day (PND) 1. Pregnant mice were euthanized by CO2 asphyxiation for fetal ovary collection. For neonatal ovary collection, pups were euthanized by decapitation on the appropriate day.
Histological methods
Fetal and neonatal ovaries were dissected and trimmed of extra tissue. They were fixed in Bouin’s solution for 2 h at room temperature, followed by dehydration through an ethanol series. Histological processing of the ovaries was performed at the Electron Microscopy & Histology Core Facility, Weill Cornell Medical College, New York. Following standard protocols for paraffin-embedded sections, ovaries were serially sectioned at 5 μm and stained with hematoxylin and eosin. Images were taken on an Olympus BX50 microscope with an Olympus DP71 digital camera. Every fifth section was marked for direct counts of oocytes at pre-diplotene and diplotene stages and four to five ovaries were analyzed at each age. A total of 10–12 sections per ovary were used for counting. To avoid bias, all ovaries were analyzed without knowledge of age. To avoid double counting of oocytes, only oocytes having a visible nucleus were counted. Oocytes at pre-diplotene stages were characterized at the leptotene stage by the appearance of thin long threads of chromatin, at the zygotene stage by regions of thicker chromosome strands and at the pachytene stage by thick highly condensed chromatin. Oocytes at the diplotene stage were recognized by areas of condensed chromatin interspersed with clear areas [
17]. The total number of pre-diplotene and diplotene oocytes for each ovary was determined by multiplying the number of pre-diplotene and diplotene oocytes by five to account for every fifth section being used in the analysis. Oocytes were counted as cysts if they were present in clusters of at least two oocytes without any intervening somatic cells. Oocytes were considered to be in primordial follicles if they contained an oocyte surrounded by a layer of flattened granulosa cells.
In vitro ovary organ culture
Ovaries dissected at 17.5 dpc were placed in culture. Ovaries were cultured in 4-well culture plates in drops of media on 0.4 μM floating filters (Millicell- CM; Millipore Corp., Bedford, MA) in 0.4 ml DMEM-Ham’s F-12 media supplemented with penicillin-streptomycin, 5X ITS-X (Life Technologies, Inc., Grand Island, NY), 0.1% BSA, 0.1% albumax, and 0.05 mg/ml L-ascorbic acid. E2 and P4 (Sigma Chemical Co., St. Louis, MO) were dissolved in dimethylsulfoxide (DMSO) at a concentration of 0.1 M and then added to culture media to achieve the desired final concentration. DMSO was added to media at the same percent as the chemical to serve as vehicle control. Ovaries were placed in culture and exposed daily to E2, P4 or both hormones at 10−6 M or DMSO alone (n = 5 ovaries per treatment group). Ovaries were divided randomly among the treatment groups. The ovaries from control and treatment were fixed in Bouin’s fixative and histologically processed.
Statistical analysis
The percent of oocytes in diplotene, percent of oocytes in follicles and percent of follicles containing pre-diplotene oocytes over time were calculated using four to five ovaries at each time point. Data are represented as mean ± SEM of nontransformed data. As counted data by nature are non-normally distributed, logarithmic transformation (Y = log [y]) was performed on the data. Statistical analyses using transformed data were performed using GraphPad Prism version 6 (GraphPad Software, San Diego, CA). Statistical differences (P < 0.05) among the means were evaluated using one-way ANOVA followed by Newman-Keuls multiple comparisons test. Effects of E2 and P4 on oocyte number, percent single oocytes, percent oocytes in diplotene and percent of follicles containing diplotene oocytes were analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons test using five ovaries per treatment group. All results are presented as mean ± SEM of nontransformed data.
Discussion
Here we investigated the relationship between two critical events in mammalian oogenesis, primordial follicle formation and diplotene arrest. We confirmed that the earliest diplotene oocytes were observed at 17.5 dpc and gradually increased over time. In previous studies from our lab, the earliest age that primordial follicles were reported was 17.5 dpc [
6]. However, here we observed a small percentage of oocytes in follicles even earlier, at 16.5 dpc. We also found primordial follicles containing pre-diplotene oocytes, supporting the idea that oocytes do not need to reach diplotene arrest before they can become enclosed in primordial follicles. Furthermore, oocytes within individual germ cell cysts do not appear to proceed through meiosis synchronously. Finally, progesterone treatment delayed meiotic progression of oocytes in follicles.
Borum in 1961 reported that mouse oocytes begin to reach the diplotene stage at 17.5 dpc in the Street inbred strain of mice [
2]. A more recent study using CD1 outbred mice reported that the first diplotene oocytes were observed at 18.5 dpc [
18]. However, for that study, the sample size was limited to only 200 oocyte nuclei at each age. We reexamined this question in the same strain (CD1) and found oocytes in diplotene arrest as early as 17.5 dpc in agreement with the original studies of Borum. Further, we see an increase in the percent of diplotene oocytes from PND1 to PND3 and no further increase to PND5. Previous reports suggest that most oocytes have arrested in the diplotene stage by PND5 and consistent with this in our studies 97% of the oocytes were in diplotene at PND5.
Inhibition of the synaptonemal complex protein SYCP1 in rats led to premature arrival of oocytes at the diplotene stage and also resulted in accelerated primordial follicle assembly [
11]. These observations suggested that diplotene arrest is developmentally linked with follicle formation in rodents. Supporting this notion, Wang and colleagues found that in newborn mice, all oocytes in primordial follicles were at the dictyate (late diplotene) stage and no follicles containing earlier stages were observed [
19]. However, our results here suggest that meiotic stage and primordial follicle formation are not closely linked.
Stra8 deficient female mice have been previously shown to have a meiotic initiation block at 13.5 dpc to 14.5 dpc [
20]. The authors postulated that if oocytes were required to enter meiosis for follicles to assemble then
Stra8 deficient ovarian germ cells would not undergo follicle formation or activation. However, the germ cells in
Stra8 deficient ovaries did become enclosed in granulosa cells and developed to advanced stages [
21]. Thus, some studies suggest that progression of oocytes to the diplotene stage is a prerequisite to form follicles in rodents while other studies including data presented here do not support this idea. In cattle, up to 80% of oocytes in primordial follicles are at prediplotene stages during fetal development suggesting that oocytes are not required to reach the diplotene stage before follicles are able to form in bovine ovaries [
16]. Further investigation is necessary determine the exact link between primordial follicle formation and meiotic stage.
Here, we examined the effects of E
2 and P
4 on progression of oocytes to the diplotene stage. Surprisingly, P
4 but not E
2 delayed meiotic progression, decreasing the percent of follicles containing diplotene oocytes. In previous studies, exposure of pregnant C57BL/6 females to the estrogenic compound BPA, disrupted the process of meiotic prophase [
15]. Oocytes from female fetuses had defects in synapsis and increased recombination resulting in higher levels of aneuploidy. This difference may be due to differences in the specific time period examined or route of hormone exposure. BPA exposure spanned 11.5 dpc to 18.5 dpc, while the fetal ovaries in our study were harvested at 17.5 dpc and exposed to hormones in organ culture for 4 days. There may also be differences depending on which estrogenic compound is used. Finally, Susiarjo and colleagues examined chromosomal defects while we examined progression to the diplotene stage.
Previous work from our lab demonstrated that exposure to P
4 or E
2, as well as synthetic estrogens, BPA, diethylstilbestrol or ethinyl estradiol delayed germ cell cyst breakdown and primordial follicle formation [
14,
22]. In addition, estrogens at some concentrations also altered the oocyte loss that accompanies cyst breakdown. Here we found that P
4 or E
2 had no effect on cyst breakdown, primordial follicle formation or oocyte survival. The previous studies began hormone exposure at PND1 while in the current work hormone treatment began earlier at 17.5 dpc and this may be outside the window of sensitivity. Interestingly, in a previous study using rats, P
4 but not E
2 significantly inhibited primordial follicle assembly [
23]. In our study neither hormone affected follicle assembly, however, we observed an effect of P
4 on meiotic progression. It is also notable that there was no significant effect of P
4 and E
2 together on meiotic progression. We would expect that since P
4 alone affects meiosis, both hormones would also have an effect. E
2 may activate signals that block the effects of P
4.
Here, we examined nuclear morphology using classic histology to analyze meiotic prophase I of perinatal oocytes so that we could address meiotic progression in the context of follicle formation and development. We wanted to use molecular tools such as antibodies that recognize meiotic marker proteins. While there are several such antibodies, most are used in the surface spread technique where oocyte nuclei are spread out and tissue structure is lost so that stage of follicle development for oocytes cannot be determined. Unfortunately, many of the antibodies do not work well in whole mount immunocytochemistry where follicle formation and development could be analyzed. We are in the process of testing meiotic prophase marker antibodies to identify one that does work in whole mount immunocytochemistry to be used in future studies.
Acknowledgements
The authors thank Joanne Fortune and Ming Yang for critical reading of the manuscript and Twinkle Chowdhury for advice on statistics. In addition, the authors greatly appreciate the availability of the Pitnick laboratory microscope for analysis of histological sections.